Free Courses Sale ends Soon, Get It Now
Context: Russia has approved a novel corona virus vaccine for public use without the final phase of human trials. The Russian vaccine, developed by Moscow-based Gamaleya Institute, has cleared regulatory approvals in record time, less than two months after it got into human trials.
Production & availability
Apart from Gamaleya Institute’s own facility, the vaccine is supposed to be produced at a plant owned by Sistema, one of Russia’s biggest business groups. Its facility had the capacity to produce 1.5 million doses per year, and this capacity was being ramped up.
Will it come to India?
Reference:
© 2024 iasgyan. All right reserved